Roxanne E. Baumgartner

1.1k total citations · 1 hit paper
9 papers, 911 citations indexed

About

Roxanne E. Baumgartner is a scholar working on Transplantation, Immunology and Surgery. According to data from OpenAlex, Roxanne E. Baumgartner has authored 9 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Transplantation, 4 papers in Immunology and 2 papers in Surgery. Recurrent topics in Roxanne E. Baumgartner's work include Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Roxanne E. Baumgartner is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (3 papers) and Renal Transplantation Outcomes and Treatments (2 papers). Roxanne E. Baumgartner collaborates with scholars based in United States, Switzerland and Italy. Roxanne E. Baumgartner's co-authors include Linda C. Burkly, David M. Harlan, Allan D. Kirk, Douglas K. Tadaki, Justin D. Berning, S. John Swanson, D. Scott Batty, Stuart J. Knechtle, Christopher TenHoor and John H. Fechner and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and Transplantation.

In The Last Decade

Roxanne E. Baumgartner

9 papers receiving 883 citations

Hit Papers

Treatment with humanized monoclonal antibody against CD15... 1999 2026 2008 2017 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roxanne E. Baumgartner United States 6 571 306 275 109 94 9 911
J. Gibson Lanier United States 8 984 1.7× 347 1.1× 213 0.8× 131 1.2× 64 0.7× 8 1.3k
Ana M. García-Alonso Spain 15 377 0.7× 152 0.5× 151 0.5× 64 0.6× 47 0.5× 42 613
Keri Csencsits‐Smith United States 17 383 0.7× 62 0.2× 69 0.3× 135 1.2× 37 0.4× 26 686
Cynthia McSherry United States 11 604 1.1× 68 0.2× 75 0.3× 91 0.8× 30 0.3× 14 765
Dàlia Raϊch‐Regué Spain 16 518 0.9× 66 0.2× 67 0.2× 174 1.6× 36 0.4× 30 760
Mary A. Antonysamy United States 14 501 0.9× 49 0.2× 59 0.2× 106 1.0× 24 0.3× 21 686
Susan J. Almquist United States 9 88 0.2× 256 0.8× 109 0.4× 261 2.4× 37 0.4× 13 662
Adam Laing United Kingdom 7 655 1.1× 53 0.2× 55 0.2× 163 1.5× 58 0.6× 11 844
Fumihiro Azuma Japan 10 330 0.6× 63 0.2× 48 0.2× 89 0.8× 79 0.8× 22 568
Andrew Medvec United States 8 455 0.8× 54 0.2× 44 0.2× 134 1.2× 70 0.7× 8 736

Countries citing papers authored by Roxanne E. Baumgartner

Since Specialization
Citations

This map shows the geographic impact of Roxanne E. Baumgartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxanne E. Baumgartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxanne E. Baumgartner more than expected).

Fields of papers citing papers by Roxanne E. Baumgartner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxanne E. Baumgartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxanne E. Baumgartner. The network helps show where Roxanne E. Baumgartner may publish in the future.

Co-authorship network of co-authors of Roxanne E. Baumgartner

This figure shows the co-authorship network connecting the top 25 collaborators of Roxanne E. Baumgartner. A scholar is included among the top collaborators of Roxanne E. Baumgartner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxanne E. Baumgartner. Roxanne E. Baumgartner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Eapen, Alex K., et al.. (2007). A 28-day oral (dietary) toxicity study of sucromalt in Sprague–Dawley rats. Food and Chemical Toxicology. 45(11). 2304–2311. 7 indexed citations
2.
Baumgartner, Roxanne E., Pamela J. Durant, Yvonne Van Gessel, et al.. (2002). Evidence for the requirement of T cell costimulation in the pathogenesis of natural Pneumocystis carinii pulmonary infection. Microbial Pathogenesis. 33(5). 193–201. 5 indexed citations
3.
Elster, Eric A., He Xu, Douglas K. Tadaki, et al.. (2001). TREATMENT WITH THE HUMANIZED CD154-SPECIFIC MONOCLONAL ANTIBODY, hu5C8, PREVENTS ACUTE REJECTION OF PRIMARY SKIN ALLOGRAFTS IN NONHUMAN PRIMATES1. Transplantation. 72(9). 1473–1478. 75 indexed citations
5.
Haddad, Diana, Martha Sedegah, Yupin Charoenvit, et al.. (2000). Plasmid Vaccine Expressing Granulocyte-Macrophage Colony-Stimulating Factor Attracts Infiltrates Including Immature Dendritic Cells into Injected Muscles. The Journal of Immunology. 165(7). 3772–3781. 93 indexed citations
6.
Kirk, Allan D., Douglas K. Tadaki, He Xu, et al.. (2000). PRIMATE ALLOTRANSPLANTATION USING COSTIMULATION BLOCKADE.. Transplantation. 69(Supplement). S414–S414. 3 indexed citations
7.
Elster, Eric A., He Xu, Linda C. Burkly, et al.. (2000). PRIMARY SKIN ALLOGRAFT ACCEPTANCE WITH ANTI-CD154 IN A NON-HUMAN PRIMATE MODEL.. Transplantation. 69(Supplement). S239–S239. 3 indexed citations
8.
Kirk, Allan D., Linda C. Burkly, D. Scott Batty, et al.. (1999). Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Medicine. 5(6). 686–693. 666 indexed citations breakdown →
9.
Morris, Patrick J., et al.. (1989). Hemochromatosis in a Greater Indian Hill Mynah (Gracula religiosa): Case Report and Review of the Literature. 3(2). 87–87. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026